Acquired myasthenia gravis
Term · Chemistry · MLC-T-CHM-000153
An autoimmune disorder characterized by muscle weakness and fatigue, resulting from antibodies targeting acetylcholine receptors at the neuromuscular junction. This leads to impaired signal transmission between nerves and muscles. The condition can affect muscles controlling eye movement, facial expression, swallowing, and breathing, with severity fluctuating over time.
| Identifier | MLC-T-CHM-000153 |
|---|---|
| Field | Chemistry |
| Subject | Chemistry and Human Health |
| References | PAC, 2012, 84, 1113. 'IUPAC glossary of terms used in immunotoxicology (IUPAC Recommendations 2012)' on page 1216 (https://doi.org/10.1351/PAC-REC-11-06-03) |
| See also | Autoimmune disease; Lambert-Eaton myasthenic syndrome; Autoimmune; Idiopathic; Thymic |
Record as JSON
{
"id": "MLC-T-CHM-000153",
"term": "Acquired myasthenia gravis",
"field": "Chemistry",
"definition": "An autoimmune disorder characterized by muscle weakness and fatigue, resulting from antibodies targeting acetylcholine receptors at the neuromuscular junction. This leads to impaired signal transmission between nerves and muscles. The condition can affect muscles controlling eye movement, facial expression, swallowing, and breathing, with severity fluctuating over time.",
"subject": "Chemistry and Human Health",
"see_also": [
"autoimmune disease",
"Lambert-Eaton myasthenic syndrome",
"autoimmune",
"idiopathic",
"thymic"
],
"references": [
"PAC, 2012, 84, 1113. 'IUPAC glossary of terms used in immunotoxicology (IUPAC Recommendations 2012)' on page 1216 (https://doi.org/10.1351/PAC-REC-11-06-03)"
],
"url": "https://mlchart.com/terminology/chemistry/acquired-myasthenia-gravis/"
}
Record 159 of 13,676 in Chemistry terminology (MLC-0109). Request the full dataset.